IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Active, not recruiting · NCT04400994 · Registry updated 2025-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Active, not recruiting | Phase 2 | 2025-07-08 | NCT04400994 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Medicine | Central | Hong Kong | 1 |